MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, ELDN has $146,667K in assets. $46,209K in debts. $6,152K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
843.91%
Quick Ratio
843.91%
Cash Ratio
45.71%
Debt to Asset Ratio
31.51%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • In-process research and developm...
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Convertible preferred stock, val...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
6,152 22,808 3,669 5,741
Short-term investments
104,937 110,528 89,732 101,829
Prepaid expenses and other current assets
2,485 2,352 2,900 3,834
Total current assets
113,574 135,688 96,301 111,404
Operating lease asset, net
530 613 694 773
In-process research and development
32,386 32,386 32,386 32,386
Other assets
177 322 476 346
Total assets
146,667 169,009 129,857 144,909
Accounts payable
6,585 3,627 4,627 5,831
Current operating lease liabilities
369 358 346 336
Accrued expenses and other liabilities
6,504 14,359 9,323 7,552
Total current liabilities
13,458 18,344 14,296 13,719
Deferred tax liabilities
2,187 2,187 2,183 2,183
Non-current operating lease liabilities
186 283 376 467
Warrant liabilities
30,378 11,416 21,948 22,512
Total liabilities
46,209 32,230 38,803 38,881
Convertible preferred stock, value-Series XNon Voting Convertible Preferred Stock
2,151 2,151 2,151 2,151
Convertible preferred stock, value-Series X1Non Voting Convertible Preferred Stock
53,543 53,543 53,543 53,543
Common stock, 0.001 par value, 300,000,000 shares authorized at march 31, 2026 and december 31, 2025 75,851,722 and 75,430,033 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
76 75 60 60
Additional paid-in capital
484,988 482,189 426,047 423,619
Accumulated other comprehensive income (loss)
-72 24 9 -48
Accumulated deficit
-440,228 -401,203 -390,756 -373,297
Total stockholders equity
44,764 81,085 35,360 50,334
Total liabilities, convertible preferred stock and stockholders' equity
146,667 169,009 129,857 144,909
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$104,937K (-9.84%↓ Y/Y)Cash and cashequivalents$6,152K (-27.59%↓ Y/Y)Prepaid expenses andother current assets$2,485K (-12.41%↓ Y/Y)Total current assets$113,574K (-11.07%↓ Y/Y)In-process research anddevelopment$32,386K (0.00%↑ Y/Y)Operating lease asset, net$530K (-37.65%↓ Y/Y)Other assets$177K (-50.00%↓ Y/Y)Total assets$146,667K (-9.08%↓ Y/Y)Total liabilities,convertible preferred stock...$146,667K (-9.08%↓ Y/Y)Convertible preferredstock, value-Series...$53,543K (0.00%↑ Y/Y)Total liabilities$46,209K (-1.11%↓ Y/Y)Total stockholdersequity$44,764K (-23.98%↓ Y/Y)Convertible preferredstock, value-Series...$2,151K (0.00%↑ Y/Y)Accumulated deficit-$440,228K (-21.58%↓ Y/Y)Accumulated othercomprehensive income (loss)-$72K (-300.00%↓ Y/Y)Warrant liabilities$30,378K (-12.72%↓ Y/Y)Total currentliabilities$13,458K (46.52%↑ Y/Y)Deferred tax liabilities$2,187K (0.18%↑ Y/Y)Non-current operating leaseliabilities$186K (-66.49%↓ Y/Y)Additional paid-in capital$484,988K (15.22%↑ Y/Y)Common stock, 0.001 parvalue, 300,000,000...$76K (26.67%↑ Y/Y)Accounts payable$6,585K (126.99%↑ Y/Y)Accrued expenses andother liabilities$6,504K (9.15%↑ Y/Y)Current operating leaseliabilities$369K (13.54%↑ Y/Y)

Eledon Pharmaceuticals, Inc. (ELDN)

Eledon Pharmaceuticals, Inc. (ELDN)